Logo1
SET - 10th Annual Sanctuary of Endovascular Therapies Conference
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Objective 1: Discuss diagnostic and treatment for carotid artery, aortic aneurysms, thoracic artery grafts and peripheral arterial/venous diseases
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Objective 2: Describe the nuances of vascular anatomy as they relate to case selection
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Compare current and future medical, surgical and endovascular treatment options for infrainguinal interventions
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Discuss the Bergeron technique for direct carotid access and its application in carotid stenting and stroke intervention cases involving disease that precludes safe transfemoral catheterization
Discuss effectively implementing technology such as EMRs, while optimizing staff and allocating resources to improve patient care and enhance efficiency
Develop strategies towards integrated care using open collaboration and team-based services to provide better care while lowering costs
Discuss the advent of novel technologies that allow percutaneous interventions in increasingly complex arterial disease that once required surgical intervention.
List the various strengths and intrinsic benefits when selecting from available stent designs while considering SFA anatomy and diverse disease processes for improved outcomes.
Discuss FDA approved athrectomy devices currently available and their function and application in the treatment of PAD.
Name the benefits of Drug-Eluting Balloon (DEB) technology
Review current trends comparing successful treatment of lower extremity occlusive disease
Compare risks and benefits of endovascular intervention with surgical approaches
Review the most significant articles presented in the Journal of Vascular Surgery during 2014
Discuss their application in endovascular management of disease
Review the most provocative articles presented in the Journal of Vascular and Interventional Radiology during 2014
Discuss the highlights and trending endovascular therapies
Define the role of endoscopy in the management of variceal hemorrhage and will be able to discuss endoscopic treatment options
Review the role of TIPS as a major advancement in the treatment of complications of portal hypertension and discuss indications and technical improvements
Discuss the physiologic alterations that may lead to increased mortality in patients of advanced age with severe underlying liver disease
Explain the role of liver transplantation in end stage liver disease and discuss appropriate patient selection
Discuss the mechanisms of AVF maturation and review endovascular ligation techniques for venous side branches.
Discuss the innovative technique to simplify tunneled venous access and potential benefits offered by this new approach over standard techniques.
Name the causes of Type III endoleaks relating to defective device material, extreme angulation of a segment predisposing to fracture, and improper overlap of the modular components during insertion
Describe a novel technique for hybrid aortic arch reconstruction: the deployment cuff technique
Discuss the possibilities offered by modifying commercially available devices in instances of TAAA with unfavorable anatomy
Discuss the use of adjunct hybrid reconstruction techniques in complex cases requiring multilevel revascularization
Review the incidence of complications regarding the presence of large primary entry tears in thoracic aortic dissections and discuss the benefits of more aggressive therapy
Name the complexities of ascending aorta dissections regarding endovascular repair and discuss trending multilayered stent advancements
Discuss the use of stent-grafts in combination with open surgery when treating patients with complex aortic arch pathology
Review the treatment of valvular heart disease since the advent of transcatheter techniques for repair or replacement and discuss revolutionary procedural refinements and device developments
Review advancements in technology such as 3D imaging, fusion imaging and IVUS and discuss their benefits and application in EVAR procedures
Review anatomical suitability for treatment and discuss iliac branch device techniques that lead to successful outcomes
Discuss the challenge presented by the caudal orientation of visceral vessels in FEVAR and assess the advantages of UE access to avoid complications
Discuss the APTUS EndoStapling System and the benefits of its use in EVAR procedures and in the revision of endovascular grafts that have exhibited migration or leaks
Review the innovative Nellix Endovascular Aneurysm Sealing (EVAS) System for the repair of infrarenal abdominal aortic aneurysms and compare it to traditional EVAR techniques
Review current distal protection devices, discuss their use during carotid artery stenting (CAS) and compare capture efficiency
Discuss the effectiveness of flow reversal as an alternative means of cerebral protection during CAS placement
Discuss the Gore SCAFFOLD study and discuss the potential advantages offered in this next-generation device design
Review current revascularization devices and latest techniques in stroke treatment and discuss recommendations to improve clinical outcomes
Review studies comparing CAS and CEA stroke rates and discuss three major advances in CAS that will make current RCTs obsolete
Review case presentations and assess the merits and risks of differing approaches to treating pedal ischemia
Explain the unique technique to promote a nonsurgical anastamosis using magnetic catheters in cases of pediatric esophageal atresia
Discuss the feasibility and utility of simulation training using a Simionix simulator to facilitate technical angiography skill acquisition and catheter manipulation proficiency
Review endovascular revasculariation options in challeging cases subject to recurrent bypass graft occlusions
Review the history of performing damage-control laparotomy (DCL) in anticipation of abdominal compartment syndrome and discuss modern changes in protocol leading to better clinical outcomes
Define the role of endovascular management of bleeding pseudoanurysms in patients with chronic pancreatitis compared to traditional surgical techniques
Review neurointerventional tools and techniques and be introduced to innovative ways to apply them to other vascular systems
Evaluate the feasibility of using covered stents to treat urgent internal bleeding rather than standard transcatheter embolotherapy
List strategies for preventing stasis ulcers and discuss various treatments and methods such as high ligation, stripping, radiofrequency ablation, and endovenous laser therapy to prevent reoccurrence
Discuss concerns when dealing with venous ulcers and treatments specific to the bariatric patient regarding issues with mobility, compliance and the challenges presented to proper diagnostic imaging
Review factors determining the risk of amputation once a diabetic patient develops a foot ulcer and discuss whether revascularization reduces the long term risk of major limb amputation in patients with diabetes
Identify criteria determining the most effective treatments specific to this challenging patient population
Assess latest IVC filter options, discuss potential complications and review results of recent IVC filter studies
Discuss increasing concerns about the risk of problems associated with retrievable IVC filters and the correlating legal ramifications concerning physicians
Discuss the increasing concerns about the risk associated with retrievable IVC filters and the correlating legal ramifications concerning physicians
Objective 4: Review identification and management strategies for complications following endovascular revascularization
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 5: Analyze areas in need of clinical and translational research to advance the care of complex patients with vascular disease
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question